Generic Name

Bicisate

FDA approval date: November 23, 1994
Form: Kit

What is Bicisate?

Neurolite single photon emission computerized tomography is indicated as an adjunct to conventional CT or MRI imaging in the localization of stroke in patients in whom stroke has already been diagnosed. Neurolite is not indicated for assessment of functional viability of brain tissue. Also, Neurolite is not indicated for distinguishing between stroke and other brain lesions.

Approved To Treat

Top Global Experts

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Computational insights into the redox properties and electronic structures of [Tc=O]3+ complexes: Implications for 99mTc-radiopharmaceuticals.
Computational insights into the redox properties and electronic structures of [Tc=O]3+ complexes: Implications for 99mTc-radiopharmaceuticals.
Journal: Journal of molecular graphics & modelling
Published: November 29, 2024
Short post-injection seizure duration is associated with reduced power of ictal brain perfusion SPECT to lateralize the seizure onset zone.
Short post-injection seizure duration is associated with reduced power of ictal brain perfusion SPECT to lateralize the seizure onset zone.
Journal: EJNMMI research
Published: February 01, 2024
Impurity profiling of N,N'-ethylenebis-l-cysteine diethyl ester (Bicisate).
Impurity profiling of N,N'-ethylenebis-l-cysteine diethyl ester (Bicisate).
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 03, 2017
View All Latest Advances